InvestorsHub Logo
Followers 47
Posts 12024
Boards Moderated 0
Alias Born 09/12/2017

Re: A deleted message

Thursday, 02/28/2019 4:20:58 AM

Thursday, February 28, 2019 4:20:58 AM

Post# of 111071
Reading is fundamental:

Clinical use of stem cells in treatment of ED has been reported in a study outside the U.S. which treated seven patients with diabetes associated ED which was unresponsive to medication for at least six months with an average of 1.5 × 10(7) cord blood mononuclear cells injected intracavernously. Three additional patients with similar characteristics were used as controls. No treatment associated abnormalities were reported despite the allogeneic nature of the cells in absence of immune suppression. One month after treatment, morning erections were regained in three participants. By the third month post treatment six of the seven patients had regained morning erections. In all patients rigidity increased as the result of cord blood administration, but was not sufficient for penetration. When the patients were administered PDE5 inhibitor before coitus, two achieved penetration and experienced orgasm, and maintained for more than six months; however, one participant could not achieved penetration at ninth month. An increase in sexual desire was reported in six of the seven patients. No improvements were observed in any of the three control patients.

https://www.sec.gov/Archives/edgar/data/1187953/000114420417010361/v460135_posam.htm

Yes.the control group patients are control patients...treated with placebo or not at all as a comparison model.


Wow...just wow


LMAO!!!!!!!!!!! Next---
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News